Turn TherapeuticsTTRX
13F holders, Q1 2026 (March 31)20holders −2
1new positions
4sold out
1famous investor
$3.20avg. 13F price*
At the end of Q1 2026, 20 institutions reported holding Turn Therapeutics Inc. (TTRX) in their 13F filings, down 2 from Q4 2025. 1 opened new positions and 4 sold out. The largest holders were DDFG, Inc ($226K), Millennium Management ($223K) and Wellington Shields & Co., LLC ($210K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Turn Therapeutics Inc.
- CUSIP
- 90021W105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1K |
| Exits | 4 | $152K |
All 13F filers, Q4 2025 → Q1 2026: 33,946 shares bought and 69,871 shares sold, net −35,925 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| DDFG, Inc | 0.05% | Add +34.9% | 70,534 | $226K |
| Millennium Management | 0.00% | Reduce -27.1% | 69,757 | $223K |
| Wellington Shields & Co., LLC | 0.05% | No change | 65,732 | $210K |
| Vanguard Capital Management LLC | 0.00% | — | 49,450 | $158K |
| Tamar Securities, LLC | 0.01% | Add +100.0% | 30,000 | $96K |
| Brown Brothers Harriman & Co. | 0.00% | No change | 23,688 | $76K |
| XTX Topco Ltd | 0.00% | Reduce -21.6% | 19,727 | $63K |
| HighTower Advisors, LLC | 0.00% | No change | 19,684 | $63K |
| RVW Wealth, LLC | 0.00% | No change | 18,000 | $58K |
| Geode Capital Management, LLC | 0.00% | No change | 17,142 | $55K |
| Composition Wealth, LLC | 0.00% | No change | 16,000 | $51K |
| Bank of America Corp. | 0.00% | No change | 14,124 | $45K |
| LPL Financial LLC | 0.00% | Add +2.3% | 13,300 | $43K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 12,480 | $40K |
| Hodges Capital Management Inc. | 0.00% | No change | 10,000 | $32K |
| Morgan Stanley | 0.00% | No change | 10,000 | $32K |
| Blue Trust, Inc. | 0.00% | No change | 1,122 | $4K |
| Wells Fargo & Company | 0.00% | No change | 1,000 | $3K |
| UBS Group AG | 0.00% | New | 400 | $1K |
| Pflug Koory, LLC | 0.00% | No change | 170 | $544 |
"% of holder's portfolio" is TTRX's weight in each manager's 13F, not the share of Turn Therapeutics Inc. the manager owns.